Family Study of Fibromyalgia

Arthritis and Rheumatism

Volumn 50, Issue 3, 2004, Pages 944-952

  Arnold, Lesley M ^a,d   Hudson, James I ^b,c   Hess, Evelyn V ^a   Ware, Avis E ^a   Fritz, Deborah A ^a   Auchenbach, Megan B ^a   Starck, Linsey O ^a   Keck Jr , Paul E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b MCLEAN HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILIAL DISEASE; FEMALE; FIBROMYALGIA; HUMAN; INHERITANCE; INTERVIEW; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOOD DISORDER; PAIN; PRIORITY JOURNAL; RELATIVE; RHEUMATOID ARTHRITIS; STATISTICAL MODEL;

ADULT; BIPOLAR DISORDER; CLUSTER ANALYSIS; DEPRESSIVE DISORDER, MAJOR; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PAIN; PREVALENCE;

EID: 1542313923     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20042     Document Type: Article

References (52)

1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990;33:160-72.
2. Pellegrino MJ, Waylonis GW, Sommer A. Familial occurrence of primary fibromyalgia. Arch Phys Med Rehabil 1989;70:61-3.
3. Buskila D, Neumann L, Hazanov I, Carmi R. Familial aggregation in the fibromyalgia syndrome. Semin Arthritis Rheum 1996;26:605-11.
4. Buskila D, Neumann L. Fibromyalgia syndrome (FM) and nonarticular tenderness in relatives of patients with FM. J Rheumatol 1997;24:941-4.
5. Hudson JI, Hudson MS, Pliner LF, Goldenberg DL, Pope HG Jr. Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry 1985;142:441-6.
6. Hudson JI, Goldenberg DL, Pope HG Jr, Keck PE Jr, Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 1992;92:363-7.
7. Thompson WD, Orvaschel H, Prusoff BA, Kidd KK. An evaluation of the family history method for ascertaining psychiatric disorders. Arch Gen Psychiatry 1982;39:53-8.
8. Chapman TF, Mannuzza S, Klein DF, Fyer AJ. Effects of informant mental disorder on psychiatric family history data. Am J Psychiatry 1994;151:574-9.
9. Tsuang MT, Faraone SV. The genetics of mood disorders. Baltimore: The Johns Hopkins University Press; 1990.
10. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000;157:1552-62.
11. Wells KB, Golding JM, Burnam MA. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 1988;145:976-81.
12. Dickens C, McGowan L, Clark-Carter D, Creed F. Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosom Med 2002;64:52-60.
13. Klerman GL, Weissman MM. Increasing rates of depression. JAMA 1989;261:2229-35.
14. Arnett FC, Edworthy SM, Block DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
15. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for the DSM-IV Axis I disorders-patient edition (SCID-I/P), version 2.0. New York: Biometrics Research Department, New York State Psychiatric Institute; 1995.
16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
17. Fischer AA. Pressure algometry over normal muscles: standard values, validity, and reproducibility of pressure threshold. Pain 1987;30:115-26.
18. Cott A, Parkinson W, Bell MJ, Adachi J, Bedard M, Cividino A, et al. Interrater reliability of the tender point criterion for fibromyalgia. J Rheumatol 1992;19:1955-9.
19. Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain 1992;50:133-49.
20. Pope HG Jr, Hudson JI. A supplemental interview for forms of "affective spectrum disorder." Int J Psychiatry Med 1991;21:202-32.
21. Hudson JI, Mangweth B, Pope HG Jr, De Col C, Hausmann A, Gutweniger S, et al. Family study of affective spectrum disorder. Arch Gen Psychiatry 2003;50:170-7.
22. Yunus MB, Masi AT, Aldag JC. Preliminary criteria for primary fibromyalgia syndrome (PFS): multivariate analyses of a consecutive series of PFS, other pain patients, and normal subjects. Clin Exp Rheumatol 1989;7:63-9.
23. Maxwell ME. Family Interview for Genetic Studies (FIGS). Washington, DC: National Institute of Mental Health; 1992.
24. Laird NM, Fitzmaurice GM, Schwartz AG. The analysis of case-control data: epidemiologic studies of familial aggregation. In: Sen PK, Rao CR, editors. Handbook of statistics. New York: Elsevier Science; 2000; vol. 18; p. 465-82.
25. Hudson JI, Laird NM, Betensky RA. Multivariate logistic regression for familial aggregation of two disorders. I. Development of models and methods. Am J Epidemiol 2001;153:501-5.
26. Hudson JI, Laird NM, Betensky RA, Keck PE Jr, Pope HG Jr. Multivariate logistic regression for familial aggregation of two disorders. II. Analysis of studies of eating and mood disorders. Am J Epidemiol 2001;153:506-14.
27. Mangweth B, Hudson JI, Pope HG Jr, Hausmann A, De Col C, Laird NM, et al. Family study of the aggregation of eating disorders and mood disorders. Psychol Med 2003;33:1319-23.
28. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
29. Diggle PJ, Liang K-Y, Zeger SL. Analysis of longitudinal data. Oxford: Oxford University Press; 1994.
30. Hollingshead AB. Two factor index of social position. New Haven (CT): Yale University; 1958.
31. Hudson JI, Pope HG Jr. The relationship between fibromyalgia and major depressive disorder. Rheum Dis Clin North Am 1996;22:285-303.
32. Walker EA, Keegan D, Gardner G, Sullivan M, Katon WJ, Bernstein D. Psychosocial factors in fibromyalgia and rheumatoid arthritis. I. Psychiatric diagnoses and functional disability. Psychosom Med 1997;59:565-71.
33. Kirmayer LJ, Robbins JM, Kapusta MA. Somatization and depression in fibromyalgia syndrome. Am J Psychiatry 1988;145:950-4.
34. Ahles TA, Khan SA, Yunus MB, Spiegel DA, Masi AT. Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis, and subjects without pain: a blind comparison of DSM-III diagnoses. Am J Psychiatry 1991;148:1721-6.
35. Wolfe F, Ross K, Anderson J, Russell J, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
36. White KP, Nielson WR, Harth M, Ostbye T, Speechley M. Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a representative community adult sample. J Rheumatol 2002;29:588-94.
37. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depression: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-105.
38. Arnold LM, Keck PE Jr, Welge JA. Antidepressant treatment of fibromyalgia: a meta-analysis and review. Psychosomatics 2000;41:104-13.
39. Arnold LM, Hess EV, Hudson JI, Welge JA, Berno SE, Keck PE Jr. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 2002;112:191-7.
40. Russell IJ, Vaeroy H, Javors M, Nyberg F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992;35:550-6.
41. Russell IJ, Michalek JE, Vipraio GA, Fletcher EM, Javors MA, Bowden CA. Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 1992;19:104-9.
42. Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC. Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. J Rheumatol 1992;19:90-4.
43. Schwarz MJ, Spath M, Muller-Bardorff H, Pongratz DE, Bondy B, Ackenheil M. Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients. Neurosci Lett 1999;259:196-8.
44. Charney DS. Monoamine dysfunction and the pathophysiology and treatment of depression. J Clin Psychiatry 1998;59:11-4.
45. Hirschfeld RM. History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry 2000;61 Suppl 6:4-6.
46. Bondy B, Spaeth M, Offenbaecher M, Glatzeder K, Stratz T, Schwarz M, et al. The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol Dis 1999;6:433-9.
47. Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B. Association of T102C polymorphism of the 5-HT2A receptor gene with psychiatric status in fibromyalgia syndrome. Rheumatol Int 2001;21:58-61.
48. Offenbaecher M, Bondy B, de Jonge S, Glatzeder K, Krüger M, Schoeps P, et al. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum 1999;42:2482-8.
49. Ebstein RP, Buskila D, Cohen H, Neumann L. An association between FMS and the serotonin transporter promoter region (5-HTTLPR) polymorphism and relationship to anxiety-related personality traits [abstract]. Am J Med Genet 2001;105:627.
50. Gursoy S. Absence of association of the serotonin transporter gene polymorphism with the mentally healthy subset of fibromyalgia patients. Clin Rheumatol 2002;21:194-7.
51. Petzke F, Gracely RH, Park KM, Ambrose K, Clauw DJ. What do tender points measure? Influence of distress on 4 measures of tenderness. J Rheumatol 2003;30:567-74.
52. Wolfe F. The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis 1997;56:268-71.